From the FDA Drug Label
The FDA drug label does not answer the question.
From the Research
For a 64-year-old woman with rheumatoid arthritis, I recommend a carefully tailored anesthesia plan that accounts for her specific airway and joint challenges, as outlined in the most recent study 1. The plan should begin with a thorough preoperative assessment focusing on cervical spine mobility, temporomandibular joint function, and overall disease activity.
- General anesthesia with fiberoptic intubation is often preferred due to potential difficult airway management.
- Premedication should include continuation of the patient's regular rheumatoid medications and possibly midazolam 1-2mg IV for anxiolysis.
- Induction can be achieved with propofol 1.5-2 mg/kg, fentanyl 1-2 mcg/kg, and rocuronium 0.6 mg/kg, adjusting doses for potential hepatic or renal involvement.
- Maintenance with sevoflurane or desflurane is appropriate, with careful positioning to avoid joint stress.
- Regional anesthesia techniques like peripheral nerve blocks should be considered when possible to reduce opioid requirements. Postoperatively, multimodal pain management using acetaminophen 1g IV q6h, ketorolac 15-30mg IV q6h (if no contraindications), and patient-controlled analgesia with hydromorphone or morphine helps manage pain while minimizing opioid side effects, as suggested by 1. This approach addresses the specific challenges of rheumatoid arthritis including potential airway difficulties, joint fragility, and the need for careful pain management in a patient population often already on multiple medications. The importance of a thorough preoperative evaluation and careful perioperative management is also highlighted in earlier studies 2, 3, 4, but the most recent study 1 provides the most up-to-date guidance on anesthesia management for patients with rheumatoid arthritis.